Ekofuril oral suspension 200 mg / 5ml 90ml vial complete with spoon scrapper.

$8.49

Ekofuril oral suspension 200 mg / 5ml 90ml vial complete with spoon scrapper.

Quantity:

SKU: 01837421988 Categories: , , Tags: ,

Description

Composition
Active substance:
Nifuroxazide 200.00 mg.
Excipients:
Maltitol – 350,00 mg Lactulose – 300.00 mg Povidone K-90 – 25.00 mg Xanthan gum – 20.00 mg banana flavoring – 10.00 mg methyl parahydroxybenzoate – 5.00 mg, sodium citrate dihydrate 0.015 mg anhydrous citric acid – 0.001 mg purified water – up to obtain a slurry volume of 5.0 ml.
Description:
Homogeneous suspension of yellow color with a characteristic odor.
Product form:
90 ml amber glass vial with 100 ml plastic screw-on lid. Each vial together with two-way dispensing spoon (small capacity 2.5 mL, large – 5 ml) and instructions for use placed in a pile of cardboard.
Contraindications
Hypersensitivity to nifuroxazide, nitrofuran derivatives, other ingredients pregnancy neonatal period (up to 1 month.), Prematurity
Precautions: liver disease, alcoholism, traumatic brain injury brain disease lactation children’s age (older than 1 month).
Dosage
200 mg / 5 ml
Indications
Acute bacterial diarrhea flowing without deterioration in general condition, fever, intoxication.
Interaction with other drugs
Not recommended simultaneous use with drugs that cause development disulfiramopodobnyh reactions, or depressing the central nervous system function. If you are taking any other medications (including over the counter) before using nifuroxazide consult your doctor.
Overdose
Symptoms of overdose are not known. Treatment is symptomatic.
pharmachologic effect
Pharmacological group:
The antimicrobial agent – nitrofuran.
ATC code: A07AH03.
Pharmacological properties:
Antimicrobial broad-spectrum – derivative 5-nitrofuran. Used to treat infections of the gastrointestinal tract. Nifuroxazide blocks dehydrogenase activity and inhibits the respiratory chain cycle of tricarboxylic acids and other biochemical reactions in a bacterial cell. Destroys the membranes of sensitive bacteria, it reduces the production of toxins by microorganisms. Activates the immune system, increases the activity of phagocytes and complement titer.
It is effective against Gram-positive microorganisms: Staphylococcus spp; Streptococcus spp..
Gram-negative microorganisms Salmonella spp;. Klebsiella spp;. Enterobacter spp;. Escherichia coli; Shigella spp;. Proteus spp;. Haemophilus influenzae; Campilobacter spp;. Edwarsiella spp;. Citrobacter spp;. Vibrio cholerae; Yersinia enterocolitica.
Nifuroxazide no effect on the state of the normal microflora of the human gut. In acute bacterial diarrhea restoring intestinal eubioz. When infected by viruses enterotropnymi prevents the development of bacterial superinfection.
Pharmacokinetics:
After oral administration nifuroxazide practically not absorbed from the digestive tract and its antibacterial effect has only in the lumen of the intestine. Nifuroxazide output intestine: 20% unchanged and the remainder nifuroxazide – chemically modified.
Pregnancy and breast-feeding
Use of the drug during pregnancy is contraindicated. During the period of breast-feeding before using medication should consult a physician.
Conditions of supply of pharmacies
Without recipe.
side effects
Allergic reactions (rash, urticaria, angioneurotic edema, anaphylactic shock). If any of these instructions side effects are compounded, or if you notice any other side effects not mentioned in the instructions, tell your doctor.
special instructions
In the treatment of diarrhea at the same time with the therapy should be carried out nifuroxazide rehydration therapy. Treatment of diarrhea in children under 3 years old should be under the supervision of a physician. In the case of bacterial diarrhea with signs of systemic damage (deterioration of general condition, fever, symptoms of intoxication or infection) should consult a doctor to decide on the use of antibacterial drugs with systemic action.
When the symptoms of hypersensitivity reactions (rash and itching, difficulty breathing, shortness of breath) should stop taking the drug. In connection with the content of methyl parahydroxybenzoate drug can cause allergic reactions (possibly delayed).
Drinking alcohol during therapy nifuroxazide prohibited.
The effect on the ability to drive and carry out work requiring high concentration and psychomotor speed reactions.
The drug has no negative impact on the ability to drive and / or other mechanisms.
Storage conditions
In the dark place at a temperature not higher than 25 ° C. Do not freeze. Opened vials stored no longer than 7 days. Keep out of the reach of children.
Dosing and Administration
Inside. Used for dispensing two-sided scoop, a volume of 2.5 ml on one side and 5 ml to the other side. Before use, the suspension must be shaken well. Children aged 1-6 months, 2.5 ml of 2 or 3 times a day (8-12 hours apart). Children aged 6 months to 3 years 2.5 ml, 3 times a day (the interval between doses 8 hours). Children aged from 3 to 6 years: 5 ml 3 times per day (the interval between doses 8 hours). Children 6 to 18 years: 5 ml 3-4 times a day (range 6-8 hours between doses). Adults: 5 ml of 4 times a day (interval 6 hours between doses). The duration of treatment 5-7 days, but no more than 7 days. If within the first three days did not improve, you should consult a doctor. Apply the drug should be according to the method of application and the dosages specified in the instruction. If necessary, prior to application of the drug should consult a physician.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist

Additional information

Weight0.100 kg
Manufacturer

ABBA RUS

There are no reviews yet.

Add your review